↓ Skip to main content

Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
12 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
82 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
Published in
Journal for Immunotherapy of Cancer, September 2019
DOI 10.1186/s40425-019-0716-8
Pubmed ID
Authors

João Calmeiro, Mylène Carrascal, Célia Gomes, Amílcar Falcão, Maria Teresa Cruz, Bruno Miguel Neves

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 82 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 16%
Researcher 11 13%
Student > Master 8 10%
Student > Bachelor 5 6%
Student > Doctoral Student 4 5%
Other 10 12%
Unknown 31 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 12%
Immunology and Microbiology 9 11%
Medicine and Dentistry 7 9%
Chemistry 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 12 15%
Unknown 35 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2021.
All research outputs
#6,377,981
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,514
of 3,424 outputs
Outputs of similar age
#104,329
of 350,411 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#42
of 75 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,411 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.